00

Dong-E-E-Jiao Co LtdSHE 000423 Stock Report

Last reporting period 30 Jun, 2024

Updated 18 Sep, 2024

Last price

Market cap $B

4.224

Middle

Exchange

XSHE - Shenzhen Stock Exchange

000423.SZ Stock Analysis

00

Uncovered

Dong-E-E-Jiao Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

132/100

High score

Market cap $B

4.224

Dividend yield

4.24 %

Shares outstanding

643.98 B

Dong-E-E-Jiao Co., Ltd. engages in the research and development, manufacturing and sale of proprietary Chinese medicine, health care products, and biological drugs. The company is headquartered in Liaocheng, Shandong and currently employs 4,180 full-time employees. The firm distributes its Ejiao and Ejiao series products under the brand name of Dong-E E-Jiao. The firm is also involved in the production and sale of medical instrument and pharmaceutical excipients, as well as pharmaceutical trading business. The firm operates its business in domestic market, with East China and South China as its main markets.

View Section: Eyestock Rating